Bryan H King

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Psychiatric assessment of severe presentations in autism spectrum disorders and intellectual disability
    Bryan H King
    Department of Psychiatry and Behavioral Medicine, Seattle Children s Autism Center, Seattle Children s Hospital, Seattle, WA, USA Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA Electronic address
    Child Adolesc Psychiatr Clin N Am 23:1-14. 2014
  2. pmc Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism
    Bryan H King
    Seattle Children s Hospital, University of Washington, 4800 Sand Point Way NE, Seattle, WA 98105, USA
    Arch Gen Psychiatry 66:583-90. 2009
  3. doi request reprint Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial
    Bryan H King
    Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle2Department of Psychiatry and Behavioral Medicine, Seattle Children s Hospital, Washington
    JAMA Pediatr 167:1045-52. 2013
  4. doi request reprint Revisiting the relationship between autism and schizophrenia: toward an integrated neurobiology
    Nina de Lacy
    University of Washington and Seattle Children s Hospital, Seattle, Washington 98195, USA
    Annu Rev Clin Psychol 9:555-87. 2013

Detail Information

Publications4

  1. ncbi request reprint Psychiatric assessment of severe presentations in autism spectrum disorders and intellectual disability
    Bryan H King
    Department of Psychiatry and Behavioral Medicine, Seattle Children s Autism Center, Seattle Children s Hospital, Seattle, WA, USA Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA Electronic address
    Child Adolesc Psychiatr Clin N Am 23:1-14. 2014
    ..Examples of how the consideration of each of these domains may inform the diagnostic formulation are highlighted. ..
  2. pmc Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism
    Bryan H King
    Seattle Children s Hospital, University of Washington, 4800 Sand Point Way NE, Seattle, WA 98105, USA
    Arch Gen Psychiatry 66:583-90. 2009
    ..Selective serotonin reuptake inhibitors are widely prescribed for children with autism spectrum disorders...
  3. doi request reprint Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial
    Bryan H King
    Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle2Department of Psychiatry and Behavioral Medicine, Seattle Children s Hospital, Washington
    JAMA Pediatr 167:1045-52. 2013
    ..The finding of factors that differentially predict the likelihood of response to placebo over that of an active drug could have a significant impact on study design in this population...
  4. doi request reprint Revisiting the relationship between autism and schizophrenia: toward an integrated neurobiology
    Nina de Lacy
    University of Washington and Seattle Children s Hospital, Seattle, Washington 98195, USA
    Annu Rev Clin Psychol 9:555-87. 2013
    ..In so doing, the door is opened to the consideration of new therapeutics that are developed based upon molecular, synaptic, and systems targets common to both disorders...

Research Grants1

  1. 2/4-RUPP Autism Network: Guanfacine for the Treatment of Hyperactivity in PDD
    Bryan H King; Fiscal Year: 2010
    ..The role of gene variants and urinary adrenergic/noradrenergic measures as biomarkers in moderating response to guanfacine on primary efficacy measures and adverse effects will be explored. ..